<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - BUDESONIDE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>BUDESONIDE</h1>

        <p><a href="../drugClass/PHP34650.html">CORTICOSTEROIDS (INHALED)</a><a href="../drugClass/PHP34623.html">CORTICOSTEROIDS (SYSTEMIC)</a><a href="../drugClass/PHP34648.html">CORTICOSTEROIDS (INTRANASAL)</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#exceptionsToLegalCategory" data-toggle="tab">Exceptions to legal category</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prophylaxis of mild to moderate asthma (in patients stabilised on twice daily dose)</span>,
            </h4>
            <p class="specificity"><span class="route">By inhalation of powder</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                200&#8211;400 micrograms once daily (max. per dose 800 micrograms), dose to be given in the evening.</li>
              <li class="dose child"><strong>For children 6&#8211;11 years</strong><br/>
                200&#8211;400 micrograms once daily, dose to be given in the evening.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                200&#8211;400 micrograms once daily (max. per dose 800 micrograms), dose to be given in the evening.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prophylaxis of asthma</span>,
            </h4>
            <p class="specificity"><span class="route">By inhalation of nebulised suspension</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100&#8211;800 micrograms twice daily, dose to be adjusted as necessary.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 0.25&#8211;1 mg twice daily, adjusted according to response, doses higher than recommended max. may be used in severe disease; maximum 2 mg per day.</li>
              <li class="dose child"><strong>For children 6&#8211;11 years</strong><br/>
                100&#8211;400 micrograms twice daily, dose to be adjusted as necessary.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                100&#8211;800 micrograms twice daily, dose to be adjusted as necessary.</li>
              <li class="dose child"><strong>For children 6 months&#8211;11 years</strong><br/>
                125&#8211;500 micrograms twice daily, adjusted according to response; maximum 2 mg per day.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                Initially 0.25&#8211;1 mg twice daily, adjusted according to response, doses higher than recommended max. may be used in severe disease; maximum 2 mg per day.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prophylaxis and treatment of allergic and vasomotor rhinitis</span>,
            </h4>
            <p class="specificity"><span class="route">By intranasal administration</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 200 micrograms daily, dose to be administered into each nostril in the morning, alternatively initially 100 micrograms twice daily, dose to be administered to each nostril; reduced to 100 micrograms daily, dose to be administered into each nostril, dose can be reduced when control achieved.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                Initially 200 micrograms daily, dose to be administered into each nostril in the morning, alternatively initially 100 micrograms twice daily, dose to be administered to each nostril; reduced to 100 micrograms daily, dose to be administered into each nostril, dose can be reduced when control achieved.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Nasal polyps</span>,
            </h4>
            <p class="specificity"><span class="route">By intranasal administration</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100 micrograms twice daily for up to 3 months, dose to be administered into each nostril.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                100 micrograms twice daily for up to 3 months, dose to be administered into each nostril.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
            <section class="potency">
              <h3>Potency of preperations</h3>
              <p>Dose adjustments may be required for some inhaler devices, see under individual preparations.</p>
            </section>
      </section>




      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

      </section>




      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph></h3>
              <p>Budesonide nebuliser suspension is not suitable for use in ultrasonic nebulisers.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in children</h3>
              <p>Capsules can be opened and the contents mixed with apple or orange juice.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Granules should be placed on tongue and washed down with water without chewing.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="generalPatientAdvice">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph></h3>
              <p>With high doses, a steroid card should be supplied.</p><p>Patients or carers should be given advice on how to administer budesonide dry powder inhaler and nebuliser suspension.</p>
            </section>
            <section class="generalPatientAdvice">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Patients or carers should be given advice on how to administer budesonide granules.</p>
            </section>
            <section class="generalPatientAdvice">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Budesonide inhaler for asthma prevention (prophylaxis)</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/budesonide-inhaler-asthma-prevention-prophylaxis">www.medicinesforchildren.org.uk/budesonide-inhaler-asthma-prevention-prophylaxis</xref>
            </p>
            </section>
      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>With systemic use:</strong>
            autoimmune hepatitis in adults
          </li>
        </ul>
      </section>



      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use or <ph outputclass="route">rectal</ph> use in children</h3>
              <p>Not licensed for use in children.</p>
            </section>
            <section class="unlicensedUse">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph> in children</h3>
              <p>
            <i>Pulmicort</i>
            <tm tmtype="reg"/>
            <i>nebuliser solution</i> not licensed for use in children under 3 months; not licensed for use in bronchopulmonary dysplasia.</p>
            </section>
      </section>

      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
              <p>Flavours of granule formulations may include lemon.</p>
            </section>
      </section>







      <section class="tab-pane" id="exceptionsToLegalCategory">
        <h2>Exceptions to legal category</h2>

            <section class="exceptionsToLegalCategory">
              <h3 class="specificity">With <ph outputclass="route">intranasal</ph> use in adults</h3>
              <p>Preparations of budesonide can be sold to the public for nasal administration as a nasal spray if supplied for the prevention and treatment of seasonal allergic rhinitis in adults over 18 years subject to max. single dose of 200&#8239;micrograms per nostril, max. daily dose of 200&#8239;micrograms per nostril for max. period of 3 months, and a pack size of 10&#8239;mg.</p>
            </section>
      </section>


      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of BUDESONIDE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        

            <div id="PHP000089"><a href="../medicinalForm/PHP000089.html" data-target="#PHP000089" data-action="load">Modified-release tablet</a></div>
            <div id="PHP75488"><a href="../medicinalForm/PHP75488.html" data-target="#PHP75488" data-action="load">Modified-release capsule</a></div>
            <div id="PHP75563"><a href="../medicinalForm/PHP75563.html" data-target="#PHP75563" data-action="load">Gastro-resistant capsule</a></div>
            <div id="PHP76038"><a href="../medicinalForm/PHP76038.html" data-target="#PHP76038" data-action="load">Gastro-resistant granules</a></div>
            <div id="PHP75805"><a href="../medicinalForm/PHP75805.html" data-target="#PHP75805" data-action="load">Inhalation powder</a></div>
            <div id="PHP75422"><a href="../medicinalForm/PHP75422.html" data-target="#PHP75422" data-action="load">Nebuliser liquid</a></div>
            <div id="PHP75891"><a href="../medicinalForm/PHP75891.html" data-target="#PHP75891" data-action="load">Foam</a></div>
            <div id="PHP75652"><a href="../medicinalForm/PHP75652.html" data-target="#PHP75652" data-action="load">Enema</a></div>
            <div id="PHP75730"><a href="../medicinalForm/PHP75730.html" data-target="#PHP75730" data-action="load">Spray</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
